rs121908377
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_014491.4(FOXP2):c.1658G>A(p.Arg553His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R553C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_014491.4 missense
Scores
Clinical Significance
Conservation
Publications
- specific language disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- childhood apraxia of speechInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Childhood apraxia of speech Pathogenic:3Other:1
- -
- -
_x000D_ Criteria applied: PS3, PS4, PM2_SUP -
- -
FOXP2-related disorder Other:1
Variant classified as Pathogenic and reported on 08-27-2021 by GeneDx. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at